semaglutide and b12 together with for Weight Loss: What Results to Expect Cyanocobalamin Injection - Cleveland Care

Front-loading is the practical adjustment for GLP-1 patients: 3540 g at breakfast, 3540 g at lunch, 2530 g at dinner, and a 1520 g snack

SOURCE: Trinity Meds Source: Trinity Meds

doi:10.1016/j.neures.2019.12.017 143

Patient-specific factors that influence choice include: Concurrent diabetes : Patients with type 2 diabetes may have broader access through NHS prescribing pathways BMI and weight loss goals : Higher BMI patients may benefit from agents with greater weight loss efficacy Tolerability : Previous experience with gastrointestinal side effects may guide selection Injection preference : Some patients strongly prefer weekly over daily injections, or oral over injectable formulations Cardiovascular disease : Certain GLP-1 agonists have proven cardiovascular benefits, which may be relevant for high-risk patients Ultimately, the choice should be individualised through shared decision-making between patient and clinician, considering the available evidence, licensed indications, local prescribing policies, and patient preferences

GLP-1 Medications and Gallbladder Risk in Patients Who Still Have One For patients with an intact gallbladder, some observational data suggests that rapid weight loss from GLP-1 therapy may increase the risk of gallstone formation, particularly during the initial weeks of treatment